Home-based HIV counseling and testing as a gateway to earlier initiation of antiretroviral therapy

Clinical Infectious Diseases

Volumn 54, Issue 2, 2012, Pages 282-284

  Mills, Edward J ^a   Ford, Nathan ^b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b Médecins Sans Frontires   (Switzerland)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL THERAPY; CD4 LYMPHOCYTE COUNT; COST EFFECTIVENESS ANALYSIS; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EXPECTANCY; MORBIDITY; MORTALITY; NOTE; PATIENT CARE; PATIENT COUNSELING; PRIORITY JOURNAL; T CELL DEPLETION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

COUNSELING; FEMALE; HIV INFECTIONS; HOME CARE SERVICES; HUMANS; MALE;

EID: 84555209208     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir812     Document Type: Note

References (28)

1. Phillips AN, Gazzard BG, Clumeck N, Losso MH, Lundgren JD. When should antiretroviral therapy for HIV be started? BMJ 2007; 334:76-8. (Pubitemid 46122238)
2. Severe P, Juste MA, Ambroise A, et al. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N Engl J Med 2010; 363:257-65.
3. Sterne JA, May M, Costagliola D, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009; 373:1352-63.
4. Grinsztejn B RH, Cohen MS, et al. Effects of early versus delayed initiation of antiretroviral therapy (ART) on HIV clinical outcomes: results from the HPTN 052 randomized clinical trial [abstract MOAX0105]. Sixth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention. 17-20 July 2011. Rome Geneva, Switzerland: IAS.
5. Ford N, Kranzer K, Hilderbrand K, et al. Early initiation of antiretroviral therapy and associated reduction in mortality, morbidity and defaulting in a nurse-managed, community cohort in Lesotho. AIDS 2010; 24: 2645-50.
6. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
7. Mills EJ, Bakanda C, Birungi J, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med 2011; 155:209-16.
8. Cullinan K. What's good for the individual might crash the system. Health-E News. 2008. http://www.health-e.org.za/news/article.php? uid 520032045. Accessed 1 September 2011.
9. May M, Boulle A, Phiri S, et al. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. Lancet 2010; 376:449-57.
10. Kranzer K, van Schaik N, Karmue U, Middelkoop K, et al. High prevalence of self-reported undiagnosed HIV despite high coverage of HIV testing: a cross-sectional population based sero-survey in South Africa. PLos One 2011; 6:e25244.
11. Zachariah R, Harries AD, Manzi M, et al. Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport. PLoS One 2006; 1:e121.
12. Miller CM, Ketlhapile M, Rybasack-Smith H, Rosen S. Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa. Trop Med Int Health 2010; 15:48-54.
13. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med 2011; 8:e1001056.
14. Bakanda C, Birungi J, Mwesigwa R, et al. Survival of HIV-infected adolescents on antiretroviral therapy in Uganda: findings from a nationally representative cohort in Uganda. PLoS One 2011; 6:e19261.
15. Bakanda C, Birungi J, Mwesigwa R, et al. Association of aging and survival in a large HIV-infected cohort on antiretroviral therapy. AIDS 2011; 25:701-5.
16. Muula AS, Ngulube TJ, Siziya S, et al. Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review. BMC Public Health 2007; 7:63.
17. Kuwane B, Appiah K, Felix M, Grant A, Churchyard G. Expanding HIV care in Africa: making men matter in Johannesburg. Lancet 2009; 374:1329.
18. Wachira J, Kimaiyo S, Ndege S, Mamlin J, Braitstein P. What is the impact of homebased HIV counseling and testing (HBCT) on the clinical status of newly enrolled adults in a large HIV care program in western Kenya? Clin Infect Dis 2012; 54:275-81.
19. Were WA, Mermin JH, Wamai N, et al. Undiagnosed HIV infection and couple HIV discordance among household members of HIV-infected people receiving antiretroviral therapy in Uganda. J Acquir Immune Defic Syndr 2006; 43:91-5. (Pubitemid 44306494)
20. Corbett EL, Bandason T, Duong T, et al. Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a clusterrandomised trial. Lancet 2010; 376:1244-53.
21. Maher D,Waswa L, Baisley K, Karabarinde A, Unwin N, Grosskurth H. Distribution of hyperglycaemia and related cardiovascular disease risk factors in low-income countries: a cross-sectional population-based survey in rural Uganda. Int J Epidemiol 2011; 40: 160-71.
22. Decroo T, Telfer B, Biot M, et al. Distribution of antiretroviral treatment through selfforming groups of patients in Tete province, Mozambique. J Acquir Immune Defic Syndr 2011; 56:e39-e44.
23. Koenig SP, Bang H, Severe P, et al. Costeffectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti. PLoS Med 2011; 8:e1001095. doi:101371/journalpmed1001095.
24. Human Rights Watch. A testing challenge: the experience of Lesotho's universal HIV counseling and testing campaign. New York, NY: Human Rights Watch, 2008.
25. Tumwesigye E, Wana G, Kasasa S, Muganzi E, Nuwaha F. High uptake of home-based, district-wide, HIV counseling and testing in Uganda. AIDS Patient Care STDS 2010; 24:735-41.
26. Faal M, Naidoo N, Glencross DK, Venter WD, Osih R. Providing immediate CD4 count results at HIV testing improves ART initiation. J Acquir Immune Defic Syndr 2011 [published online ahead of print 18 August 2011].
27. Zachariah R, Reid SD, Chaillet P, Massaquoi M, Schouten EJ, Harries AD. Viewpoint: why do we need a point-of-care CD4 test for low-income countries? Trop Med Int Health 2011; 16:37-41.
28. De Cock KM, Mbori-Ngacha D, Marum E. Shadow on the continent: public health and HIV/AIDS in Africa in the 21st century. Lancet 2002; 360:67-72. (Pubitemid 34756497)